18 and older, any sex, with Hypertension or Medication Adherence. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Electronically Measured Mean Medication Adherence During InterventionPrimary· 3 months
The MEMS-data collected continuously over the course of the three-month intervention period will be used to calculate the primary adherence variable, which is defined as the percentage of timely (within 1 hour of anchor time) actual bottle openings out of the total number of prescribed bottle openings (# of actual once-a-day bottle openings within 1 hour of anchor time during the intervention period / # of prescribed once-a-day bottle openings during the intervention period). Only one of the anti-hypertension (AH) medications will be used to measure adherence
Group
Value
95% CI
Control Group
87
± 22
Message Group
95
± 34
Incentive Group
92
± 38
Sponsor's own description
Hypertension represents a major cardiovascular risk factor that can be controlled through the use of medications, yet medication non-adherence represents a common problem that leaves patients at elevated risk for adverse cardiovascular outcomes. Interventions to improve medication adherence have thus far been either unsuccessful or unsustainable. The investigators propose an intervention that leverages insights from behavioral economics to improve medication adherence among hypertensive patients. Strong data indicates that linking the taking of medications to daily routines ('anchoring') increases adherence, however, existing interventions built on this information have failed to create successful, long term improvements in medication adherence. This study aims to leverage behavioral economic insights to improve medication adherence to antihypertensive medications.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
NCT06909500 — A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users
· NA
· not yet recruiting
NCT05503186 — Text Intervention to Facilitate Secure Storage and Disposal of Prescription Opioids
· NA
· completed
NCT05897242 — A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults
· NA
· completed
NCT04719390 — BabySTEPs: Supportive Texts to Empower Parents
· NA
· completed
NCT05236270 — CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19)
· NA
· completed
Other recruiting trials for Hypertension
Currently open trials in the same condition.
NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A
· NA
· recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S
· recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
· NA
· recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia
· Phase 2
· recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension
· NA
· recruiting
Other Cedars-Sinai Medical Center trials
Trials by the same sponsor.
NCT06012487 — Correlates and Control of Blood Pressure Variability
· Phase 1
· not yet recruiting
NCT07495995 — SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis
· Phase 2
· not yet recruiting
NCT07413965 — TAVR vs SAVR in Severe Bicuspid Aortic Stenosis
· NA
· not yet recruiting
NCT06521021 — CHOICE to AVOID or RESIST
· NA
· not yet recruiting
NCT07499089 — Together-Breast Cancer Support Platform
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cedars-Sinai Medical Center
Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04029883.